Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”), a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine for a new era of life sciences, has announced the acquisition of Tec4med Lifescience GmbH (“Tec4med”), a solution provider and innovation leader in the pharmaceutical supply chain visibility, condition monitoring and temperature-controlled packaging space. Situated in the Frankfurt area, a global logistics hub for the pharmaceutical industry, Tec4med provides next generation pharmaceutical supply chain visibility by integrating condition monitoring, cloud and artificial intelligence (AI) solutions.
Read the full article: Cryoport Continues Its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition //
Source: https://www.prnewswire.com/news-releases/cryoport-continues-its-expansion-in-the-european-market-with-tec4med-lifescience-gmbh-acquisition-301975473.html